2013 Q4 Form 10-Q Financial Statement

#000110465913078504 Filed on October 29, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $289.0M $302.2M $242.5M
YoY Change 18.54% 24.65% 20.19%
Cost Of Revenue $38.80M $30.72M $27.97M
YoY Change 2.92% 9.83% 23.34%
Gross Profit $247.5M $269.3M $212.9M
YoY Change 22.07% 26.46% 19.4%
Gross Profit Margin 85.64% 89.1% 87.83%
Selling, General & Admin $157.2M $94.11M $68.63M
YoY Change 292.02% 37.14% 312.02%
% of Gross Profit 63.51% 34.95% 32.23%
Research & Development $121.6M $72.75M $65.16M
YoY Change 224.27% 11.66% 9.63%
% of Gross Profit 49.13% 27.02% 30.6%
Depreciation & Amortization $7.800M $7.700M $7.000M
YoY Change 8.33% 10.0% 40.0%
% of Gross Profit 3.15% 2.86% 3.29%
Operating Expenses $278.7M $166.9M $133.8M
YoY Change 259.61% 24.73% 75.82%
Operating Profit -$31.18M $104.6M $80.72M
YoY Change -124.89% 29.65% -21.61%
Interest Expense -$3.500M $4.540M $4.384M
YoY Change -7.89% 3.56% -19.05%
% of Operating Profit 4.34% 5.43%
Other Income/Expense, Net $300.0K -$3.470M $27.77M
YoY Change 200.0% -112.49% -688.31%
Pretax Income -$31.60M $101.2M $108.5M
YoY Change -125.28% -6.74% 10.42%
Income Tax -$1.300M $38.49M $30.38M
% Of Pretax Income 38.05% 28.0%
Net Earnings -$30.30M $62.70M $78.10M
YoY Change -136.37% -19.72% -7.46%
Net Earnings / Revenue -10.48% 20.75% 32.21%
Basic Earnings Per Share -$0.60 $1.25 $1.52
Diluted Earnings Per Share -$0.60 $1.17 $1.46
COMMON SHARES
Basic Shares Outstanding 50.23M shares 50.01M shares 51.51M shares
Diluted Shares Outstanding 53.69M shares 53.59M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $693.9M $716.8M $503.5M
YoY Change 44.8% 42.36% -27.51%
Cash & Equivalents $278.9M $322.2M $263.4M
Short-Term Investments $409.6M $394.6M $240.0M
Other Short-Term Assets $46.42M $35.64M $37.39M
YoY Change 31.2% -4.68% 103.21%
Inventory $47.76M $49.62M $46.85M
Prepaid Expenses $13.34M
Receivables $126.3M $130.6M $108.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $909.0M $932.7M $718.2M
YoY Change 35.98% 29.87% -15.12%
LONG-TERM ASSETS
Property, Plant & Equipment $465.0M $449.9M $439.9M
YoY Change 2.48% 2.28% 32.02%
Goodwill $10.70M $10.63M $10.42M
YoY Change 1.64% 2.02% 73.92%
Intangibles
YoY Change
Long-Term Investments $448.1M $321.9M $248.9M
YoY Change 46.58% 29.33% -0.44%
Other Assets $53.27M $53.42M $28.07M
YoY Change 98.89% 90.29% -87.14%
Total Long-Term Assets $1.179B $994.9M $929.3M
YoY Change 23.01% 7.06% 13.19%
TOTAL ASSETS
Total Short-Term Assets $909.0M $932.7M $718.2M
Total Long-Term Assets $1.179B $994.9M $929.3M
Total Assets $2.088B $1.928B $1.647B
YoY Change 28.34% 17.01% -1.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.708M $97.50M $10.13M
YoY Change -34.25% 862.49% -41.1%
Accrued Expenses $85.54M $87.64M
YoY Change 17.2% 25.91%
Deferred Revenue
YoY Change
Short-Term Debt $282.5M $213.0M $0.00
YoY Change 21630.77% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $687.7M $468.9M $227.6M
YoY Change 289.05% 106.01% -46.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $70.30M $273.4M
YoY Change -100.0% -74.29% 296.81%
Other Long-Term Liabilities $91.86M $80.34M $74.79M
YoY Change 14.87% 7.41% -3.24%
Total Long-Term Liabilities $91.86M $80.34M $74.79M
YoY Change 14.87% 7.41% -48.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $687.7M $468.9M $227.6M
Total Long-Term Liabilities $91.86M $80.34M $74.79M
Total Liabilities $783.3M $619.5M $575.8M
YoY Change 47.3% 7.6% 0.8%
SHAREHOLDERS EQUITY
Retained Earnings $728.0M $758.4M $470.2M
YoY Change 31.54% 61.27%
Common Stock $1.058B $1.030B $1.014B
YoY Change 4.07% 1.61%
Preferred Stock
YoY Change
Treasury Stock (at cost) $513.4M $513.4M $413.9M
YoY Change 9.01% 24.04%
Treasury Stock Shares 12.63M shares 12.63M shares 10.73M shares
Shareholders Equity $1.259B $1.260B $1.061B
YoY Change
Total Liabilities & Shareholders Equity $2.088B $1.928B $1.647B
YoY Change 28.34% 17.01% -1.18%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$30.30M $62.70M $78.10M
YoY Change -136.37% -19.72% -7.46%
Depreciation, Depletion And Amortization $7.800M $7.700M $7.000M
YoY Change 8.33% 10.0% 40.0%
Cash From Operating Activities $104.5M $139.3M $93.40M
YoY Change -0.67% 49.14% 15.74%
INVESTING ACTIVITIES
Capital Expenditures -$13.40M -$9.400M -$6.800M
YoY Change -36.79% 38.24% -61.8%
Acquisitions
YoY Change
Other Investing Activities -$143.0M -$166.4M $54.40M
YoY Change -0.35% -405.88% -235.66%
Cash From Investing Activities -$156.4M -$175.8M $47.60M
YoY Change -5.04% -469.33% -182.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.900M 14.40M -35.00M
YoY Change -117.84% -141.14% -8850.0%
NET CHANGE
Cash From Operating Activities 104.5M 139.3M 93.40M
Cash From Investing Activities -156.4M -175.8M 47.60M
Cash From Financing Activities 8.900M 14.40M -35.00M
Net Change In Cash -43.00M -22.10M 106.0M
YoY Change -60.69% -120.85% 358.87%
FREE CASH FLOW
Cash From Operating Activities $104.5M $139.3M $93.40M
Capital Expenditures -$13.40M -$9.400M -$6.800M
Free Cash Flow $117.9M $148.7M $100.2M
YoY Change -6.72% 48.4% 1.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50226603 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1070000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
552000 USD
CY2013Q3 uthr Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
111000 USD
CY2013Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
716530000 USD
CY2012Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
163687000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1. Organization and Business Description</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. As used in these notes to the consolidated financial statements, unless the context otherwise requires, the terms &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our,&#8221; and similar terms refer to United Therapeutics Corporation and its consolidated subsidiaries.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">We have three commercial products approved by the United States Food and Drug Administration (FDA): Remodulin</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;(treprostinil) Injection (Remodulin), Tyvaso</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;(treprostinil) Inhalation Solution (Tyvaso) and Adcirca</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;(tadalafil) tablets (Adcirca). Remodulin has also been approved in various other countries.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> </div>
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">2. Basis of Presentation</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The accompanying unaudited consolidated financial statements have been prepared in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information. Accordingly, they do not include all of the information required by United States generally accepted accounting principles (GAAP) for complete financial statements. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the accompanying notes to the consolidated financial statements contained in our Annual Report on Form&#160;10-K for the year ended as of December&#160;31, 2012, as filed with the SEC on February&#160;26, 2013.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In our management&#8217;s opinion, the accompanying consolidated financial statements contain all adjustments, including normal, recurring adjustments, necessary to fairly present our financial position as of September&#160;30, 2013, results of operations and comprehensive income for the three- and nine-month periods ended September&#160;30, 2013 and 2012, and cash flows for the nine-month periods ended September&#160;30, 2013 and 2012. Interim results are not necessarily indicative of results for an entire year.&#160;Certain prior year amounts have been reclassified to conform to current period presentation.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> </div>
CY2013Q3 us-gaap Goodwill Gross
GoodwillGross
10626000 USD
CY2012Q4 us-gaap Goodwill Gross
GoodwillGross
10530000 USD
CY2013Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
151653000 USD
CY2013Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
394612000 USD
CY2013Q3 uthr Held To Maturity Securities Debt Maturities In One Year Through Two Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesInOneYearThroughTwoYearsNetCarryingAmount
321562000 USD
CY2013Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
394863000 USD
uthr Commercial Products Number
CommercialProductsNumber
3 item
CY2013Q3 us-gaap Goodwill
Goodwill
10626000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
10530000 USD
CY2012Q4 uthr Goodwill And Other Intangibles Assets Gross
GoodwillAndOtherIntangiblesAssetsGross
22158000 USD
CY2013Q3 uthr Goodwill And Other Intangibles Assets Gross
GoodwillAndOtherIntangiblesAssetsGross
22471000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5750000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7857000 USD
CY2013Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
14614000 USD
CY2012Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
16408000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1362000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13603000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11708000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11943000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
37254000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
49617000 USD
CY2013Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17170000 USD
CY2013Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13738000 USD
CY2013Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
18709000 USD
CY2012Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
325175000 USD
CY2012Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
305253000 USD
CY2012Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
630428000 USD
CY2013Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
394612000 USD
CY2013Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
321562000 USD
CY2013Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
716174000 USD
CY2012Q4 uthr Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
445000 USD
CY2012Q4 uthr Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
175000 USD
CY2012Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
630698000 USD
CY2013Q3 uthr Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
467000 USD
CY2013Q3 uthr Held To Maturity Securities Debt Maturities In One Year Through Two Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesInOneYearThroughTwoYearsFairValue
321667000 USD
CY2013Q3 uthr Available For Sale Securities Equity Securities Investment Percentage Less Than
AvailableForSaleSecuritiesEquitySecuritiesInvestmentPercentageLessThan
0.01 pure
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
368000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3352000 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10088000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11026000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10485000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11761000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
310673 shares
CY2012Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
246401 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
665363 shares
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
406000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
1217000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
134000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
404000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
272000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
813000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
386515 shares
CY2013Q3 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
9799000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.20
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.17
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.11
CY2012Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
4384000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
4384000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
4540000 USD
CY2013Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
4540000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
13054000 USD
us-gaap Interest Expense
InterestExpense
12149000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
905000 USD
CY2013Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
47915000 USD
CY2012Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
10882000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62685000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
78111000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
204874000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
221187000 USD
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50014000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51514000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50007000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52626000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1822000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
662000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1389000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
136000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
397000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1455000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1414000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1174000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1087000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53688000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53590000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52570000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53849000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
CY2012Q3 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
6575000 USD
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
19896000 USD
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
9689000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
420000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P1Y
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
708998 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
42400000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14957000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15063000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-873000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-767000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-106000 USD
uthr Estimated Annual Effective Income Tax Rate
EstimatedAnnualEffectiveIncomeTaxRate
0.34 pure
uthr Estimated Annual Effective Income Tax Rate
EstimatedAnnualEffectiveIncomeTaxRate
0.31 pure
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
240917000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27968000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
212949000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
300006000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
30716000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
269290000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
665692000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1015835000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
470998000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
553480000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1083981000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
104649000 USD
CY2013Q3 us-gaap Revenues
Revenues
302225000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3470000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
101179000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
820647000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
92349000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
81632000 USD
us-gaap Gross Profit
GrossProfit
728298000 USD
us-gaap Gross Profit
GrossProfit
584060000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130642000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154030000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
116626000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
35385000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
932742000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
668470000 USD
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
305726000 USD
CY2012Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
5377000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453685000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
150147000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26782000 USD
CY2012Q4 us-gaap Assets
Assets
1626595000 USD
CY2013Q3 us-gaap Assets
Assets
1927657000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23506000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
93567000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
176755000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
468909000 USD
CY2013Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
212967000 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
204667000 USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
70343000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79967000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
531732000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
619542000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
621000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1626595000 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62802440 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62082007 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50177388 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50165953 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
12625052 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11916054 shares
us-gaap Revenues
Revenues
827967000 USD
us-gaap Costs And Expenses
CostsAndExpenses
506977000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
320990000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
310533000 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
197576000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10457000 USD
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1551000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
6567000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65155000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
135911000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68626000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161673000 USD
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
161749000 USD
us-gaap Costs And Expenses
CostsAndExpenses
379216000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
80719000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
293043000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1138000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3225000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31020000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31600000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27774000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22676000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
108493000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
315719000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30382000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
94532000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2052000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
64737000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
204768000 USD
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1185000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
797000 USD
CY2012Q3 uthr Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
131000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1388000 USD
uthr Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
767000 USD
uthr Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
391000 USD
CY2012Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-131000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-455000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
64000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
72000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
109000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79499000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1361000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
222548000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19855000 USD
uthr Provision For Doubtful Accounts And Inventory Writedown
ProvisionForDoubtfulAccountsAndInventoryWritedown
1455000 USD
uthr Income Tax Cash Flows
IncomeTaxCashFlows
94532000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
40568000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8902000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3303000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8823000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
2084000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19516000 USD
uthr Increase Decrease In Insurance Proceeds Receivable
IncreaseDecreaseInInsuranceProceedsReceivable
31000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4790000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12633000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6385000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-153865000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7120000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-109311000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
320846000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
218419000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
90650000 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
348001000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
439987000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1336000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-138621000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
130925000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9689000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2734000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2084000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-14001000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-119152000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
146000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
100749000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
168200000 USD
us-gaap Interest Paid Net
InterestPaidNet
4563000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
75046000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3054000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4775000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
263425000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
322230000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162676000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
13496000 USD
us-gaap Interest Expense
InterestExpense
13496000 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
35641000 USD
CY2013Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
321940000 USD
CY2013Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
5355000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449942000 USD
CY2013Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
149648000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53416000 USD
uthr Provision For Doubtful Accounts And Inventory Writedown
ProvisionForDoubtfulAccountsAndInventoryWritedown
-75000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
158432000 USD
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
70298000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80335000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
628000 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1029718000 USD
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
513437000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
758354000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
1260200000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1927657000 USD
CY2013Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
2219000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
7320000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72749000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
94111000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
177796000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
236832000 USD
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
868000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
202000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
323000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38494000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
105659000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1809000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-854000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
51000 USD
CY2013Q3 uthr Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
255000 USD
CY2013Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-255000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-818000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-70000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
83188000 USD
CY2013Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
97510000 USD
uthr Income Tax Cash Flows
IncomeTaxCashFlows
105659000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
142584000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9412000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3066000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1183000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5807000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15244000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11634000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18497000 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
438633000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
30766000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
349275000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
42438000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19896000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5807000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-24000 USD
us-gaap Interest Paid Net
InterestPaidNet
4782000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
119632000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4554000 USD

Files In Submission

Name View Source Status
0001104659-13-078504-index-headers.html Edgar Link pending
0001104659-13-078504-index.html Edgar Link pending
0001104659-13-078504.txt Edgar Link pending
0001104659-13-078504-xbrl.zip Edgar Link pending
a13-19630_110q.htm Edgar Link pending
a13-19630_1ex31d1.htm Edgar Link pending
a13-19630_1ex31d2.htm Edgar Link pending
a13-19630_1ex32d1.htm Edgar Link pending
a13-19630_1ex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uthr-20130930.xml Edgar Link completed
uthr-20130930.xsd Edgar Link pending
uthr-20130930_cal.xml Edgar Link unprocessable
uthr-20130930_def.xml Edgar Link unprocessable
uthr-20130930_lab.xml Edgar Link unprocessable
uthr-20130930_pre.xml Edgar Link unprocessable